Tyrosine Kinase Inhibitors: all 10,744 studies that test it
Page 102 of 108. Open to participants first (1,949), then studies with results posted, then the rest; newest registration first within each.
- Ph II Study of Perifosine Plus Gleevec for Patients With GISTCompletedNCT00455559Phase 2
- INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer PatientsWithdrawnNCT00455039Phase 1/2
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00452218Phase 1
- Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for ChemotherapyTerminatedNCT00452075Phase 2
- Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic SyndromesCompletedNCT00451997Phase 2
- Phase I/II Study of Neoadjuvant Lapatinib in Breast CancerCompletedNCT00450892Phase 1/2
- Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00450879Phase 1
- Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric CancerStatus unknownNCT00450203Phase 2/3
- Drug Interaction Study of Sorafenib and Rapamycin in Advanced MalignanciesCompletedNCT00449280Phase 1
- Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid TumorsCompletedNCT00448786Phase 1
- Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)CompletedNCT00446381Not applicable
- Effect of a Proton Pump Inhibitor on Gleevec® in Healthy VolunteersCompletedNCT00446004Phase 1
- Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerCompletedNCT00445042Phase 2
- Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell CarcinomaCompletedNCT00444314Phase 2
- Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)CompletedNCT00444015Phase 1
- Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With ImatinibCompletedNCT00441155Phase 1
- Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00440414Phase 3
- A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)CompletedNCT00437437Phase 1
- A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver DysfunctionCompletedNCT00437424Phase 1
- Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer PatientsCompletedNCT00437372Phase 1
- Sorafenib in Treating Patients With Advanced Solid TumorsTerminatedNCT00436579Phase 1
- ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal CancerCompletedNCT00436072Phase 1
- A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)CompletedNCT00435669Phase 1
- Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606CompletedNCT00434486Phase 1
- Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung AdenocarcinomaCompletedNCT00430261Phase 2
- A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate CancerCompletedNCT00430235Phase 2
- Effects of Imatinib Mesylate in Polycythemia VeraCompletedNCT00430066Phase 2
- Gemcitabine and Dasatinib in Advanced Solid TumorsCompletedNCT00429234Phase 1
- Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)CompletedNCT00428909Phase 1
- A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast CancerCompletedNCT00428896Phase 2
- Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical CancerWithdrawnNCT00428194Phase 1
- Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath TumorsTerminatedNCT00427583Phase 2/3
- Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass PollenCompletedNCT00426179Phase 1/2
- Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00425646Phase 2
- Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin CancerStatus unknownNCT00423397Phase 1/2
- Effect of Food on Bioavailability of a Modified Release Formulation of ImatinibCompletedNCT00422825Phase 1
- A Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaCompletedNCT00422344Phase 1
- A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00421512Phase 1
- Imatinib in Adult Patients With Metastatic Ocular MelanomaTerminatedNCT00421317Phase 2
- A Phase I Study of BMS-690514 in Combination With Paclitaxel and CarboplatinCompletedNCT00420186Phase 1
- Effect of Food on Bioavailability of Modified Release Formulations of ImatinibCompletedNCT00420043Phase 1
- Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy VolunteersCompletedNCT00418769Phase 1
- Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy SubjectsCompletedNCT00418756Phase 1
- Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic FunctionCompletedNCT00418626Phase 1
- Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic MelanomaCompletedNCT00418496Phase 1
- Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem GliomaCompletedNCT00418327Phase 1
- Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell TumorsCompletedNCT00417807Phase 1/2
- Erlotinib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00416650Phase 2
- Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00411047Phase 2
- Efficacy of SU 011248 in Head And Neck CarcinomaTerminatedNCT00408252Phase 2
- BAY-43-9006 in Advanced, Metastatic Soft Tissue SarcomasCompletedNCT00406601Phase 2
- Study Evaluating SKI-606 Administered to Healthy SubjectsCompletedNCT00406406Phase 1
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
- Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerCompletedNCT00405366Early Phase 1
- Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic CancerCompletedNCT00405210Phase 1
- Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular DegenerationWithdrawnNCT00403156Phase 1
- Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant MesotheliomaCompletedNCT00402766Phase 1
- A Study of Everolimus in Combination With Imatinib in Metastatic MelanomaTerminatedNCT00402662Phase 2
- Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard TherapyTerminatedNCT00402415Phase 1
- A Study To Test The Effect Of GW786034 (Pazopanib) On P450 EnzymesCompletedNCT00401583Phase 1
- Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaCompletedNCT00401024Phase 1
- Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2CompletedNCT00400374Phase 1
- Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal CancerCompletedNCT00400114Phase 2
- Perifosine + Sunitinib Malate for Patients With Advanced CancersCompletedNCT00399152Phase 1
- Phase I Study of Perifosine + Sorafenib for Patients With Advanced CancersCompletedNCT00398814Phase 1
- Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With GemcitabineCompletedNCT00397787Phase 2
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)CompletedNCT00391248Phase 2
- Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid LeukaemiaCompletedNCT00390897Phase 4
- Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsCompletedNCT00390156Phase 1
- Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid TumorsCompletedNCT00390000Phase 1
- Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell CarcinomaCompletedNCT00389285Phase 1/2
- Glivec in Ph Positive Lymphoblastic LeukemiaCompletedNCT00388895Phase 2
- Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid MalignanciesCompletedNCT00388427Phase 1
- Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)CompletedNCT00388076Phase 1
- Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant GliomaCompletedNCT00387933Phase 1
- Sunitinib in Treating Young Patients With Refractory Solid TumorsCompletedNCT00387920Phase 1
- Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00387322Phase 1/2
- Study To Assess Long Term Safety Of PazopanibCompletedNCT00387205Phase 1
- A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.WithdrawnNCT00386555Phase 2
- Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia PatientsCompletedNCT00386373Not applicable
- PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic DrugsCompletedNCT00385853Phase 1
- QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLCWithdrawnNCT00385398Phase 2
- Sorafenib and RAD001 Renal Cell CarcinomaCompletedNCT00384969Phase 1
- Therapeutic Strategy in Advanced Bronchioloalveolar CarcinomaCompletedNCT00384826Phase 2
- A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALLCompletedNCT00384228Phase 1/2
- Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor MalignanciesTerminatedNCT00381654Phase 1
- HKI-272 Ketoconazole Drug Interaction StudyCompletedNCT00380328Phase 1
- Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast CancerCompletedNCT00379509Phase 1
- Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the UterusCompletedNCT00378911Phase 2
- STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic LeukemiaCompletedNCT00376467Phase 2
- Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic CancerCompletedNCT00375310Phase 1
- CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's LymphomaCompletedNCT00374179Phase 1
- Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AMLCompletedNCT00373373Phase 2
- Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell CarcinomaCompletedNCT00372853Phase 1
- High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR MutationsCompletedNCT00372515Phase 1
- Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast CancerCompletedNCT00372476Phase 4
- Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell CancerCompletedNCT00371553Phase 2
- GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast CancerCompletedNCT00371488Phase 1
- A Phase I Study of Pazopanib in Adult Patients With Liver CancerCompletedNCT00370513Phase 1